spacer
spacer
Go to PDB code: 
protein links
Growth factor PDB id
1tfg
Jmol
Contents
Protein chain
112 a.a. *
Waters ×84
* Residue conservation analysis
PDB id:
1tfg
Name: Growth factor
Title: An unusual feature revealed by the crystal structure at 2.2 resolution of human transforming growth factor-beta2
Structure: Transforming growth factor, beta 2. Chain: a. Engineered: yes
Source: Homo sapiens. Human. Organism_taxid: 9606
Biol. unit: Dimer (from PQS)
Resolution:
1.95Å     R-factor:   0.194    
Authors: M.Gruetter,M.Schlunegger
Key ref: M.P.Schlunegger and M.G.Grütter (1992). An unusual feature revealed by the crystal structure at 2.2 A resolution of human transforming growth factor-beta 2. Nature, 358, 430-434. PubMed id: 1641027 DOI: 10.1038/358430a0
Date:
17-Nov-92     Release date:   31-Oct-93    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chain
Pfam   ArchSchema ?
P61812  (TGFB2_HUMAN) -  Transforming growth factor beta-2
Seq:
Struc:
414 a.a.
112 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Gene Ontology (GO) functional annotation 
  GO annot!
  Biochemical function     growth factor activity     1 term  

 

 
DOI no: 10.1038/358430a0 Nature 358:430-434 (1992)
PubMed id: 1641027  
 
 
An unusual feature revealed by the crystal structure at 2.2 A resolution of human transforming growth factor-beta 2.
M.P.Schlunegger, M.G.Grütter.
 
  ABSTRACT  
 
Transforming growth factor type beta 2 (TGF-beta 2) is a member of an expanding family of growth factors that regulate proliferation and differentiation of many different cell types. TGF-beta 2 binds to various receptors, one of which was shown to be a serine/threonine kinase. TGF-beta 2 is involved in wound healing, bone formation and modulation of immune functions. We report here the crystal structure of TGF-beta 2 at 2.2 A resolution, which reveals a novel monomer fold and dimer association. The monomer consists of two antiparallel pairs of beta-strands forming a flat curved surface and a separate, long alpha-helix. The disulphide-rich core has one disulphide bone pointing through a ring formed by the sequence motifs Cys-Ala-Gly-Ala-Cys and Cys-Lys-Cys, which are themselves connected through the cysteines. Two monomers are connected through a single disulphide bridge and associate such that the helix of one subunit interacts with the concave beta-sheet surface of the other. Four exposed loop regions might determine receptor specificity. The structure provides a suitable model for the TGF-beta s and other members of the super-family and is the basis for the analysis of the TGF-beta 2 interactions with the receptor.
 

Literature references that cite this PDB file's key reference

  PubMed id Reference
20459854 B.Funkenstein, E.Olekh, and S.B.Jakowlew (2010).
Identification of a novel transforming growth factor-beta (TGF-beta6) gene in fish: regulation in skeletal muscle by nutritional state.
  BMC Mol Biol, 11, 37.  
19161338 J.Baardsnes, C.S.Hinck, A.P.Hinck, and M.D.O'Connor-McCourt (2009).
TbetaR-II discriminates the high- and low-affinity TGF-beta isoforms via two hydrogen-bonded ion pairs.
  Biochemistry, 48, 2146-2155.  
19926516 J.Nickel, W.Sebald, J.C.Groppe, and T.D.Mueller (2009).
Intricacies of BMP receptor assembly.
  Cytokine Growth Factor Rev, 20, 367-377.  
19208630 V.Veverka, A.J.Henry, P.M.Slocombe, A.Ventom, B.Mulloy, F.W.Muskett, M.Muzylak, K.Greenslade, A.Moore, L.Zhang, J.Gong, X.Qian, C.Paszty, R.J.Taylor, M.K.Robinson, and M.D.Carr (2009).
Characterization of the Structural Features and Interactions of Sclerostin: MOLECULAR INSIGHT INTO A KEY REGULATOR OF Wnt-MEDIATED BONE FORMATION.
  J Biol Chem, 284, 10890-10900.
PDB code: 2k8p
17158104 P.M.Smallwood, J.Williams, Q.Xu, D.J.Leahy, and J.Nathans (2007).
Mutational analysis of Norrin-Frizzled4 recognition.
  J Biol Chem, 282, 4057-4068.  
17146441 T.Shimanuki, T.Hara, T.Furuya, T.Imamura, and K.Miyazono (2007).
Modulation of the functional binding sites for TGF-beta on the type II receptor leads to suppression of TGF-beta signaling.
  Oncogene, 26, 3311-3320.  
17089091 Y.Haramoto, S.Takahashi, and M.Asashima (2007).
Monomeric mature protein of Nodal-related 3 activates Xbra expression.
  Dev Genes Evol, 217, 29-37.  
16606344 C.Sieber, F.Plöger, R.Schwappacher, R.Bechtold, M.Hanke, S.Kawai, Y.Muraki, M.Katsuura, M.Kimura, M.M.Rechtman, Y.I.Henis, J.Pohl, and P.Knaus (2006).
Monomeric and dimeric GDF-5 show equal type I receptor binding and oligomerization capability and have the same biological activity.
  Biol Chem, 387, 451-460.  
16672228 M.Pieren, A.E.Prota, C.Ruch, D.Kostrewa, A.Wagner, K.Biedermann, F.K.Winkler, and K.Ballmer-Hofer (2006).
Crystal structure of the Orf virus NZ2 variant of vascular endothelial growth factor-E. Implications for receptor specificity.
  J Biol Chem, 281, 19578-19587.
PDB code: 2gnn
16465447 S.Cébe-Suarez, A.Zehnder-Fjällman, and K.Ballmer-Hofer (2006).
The role of VEGF receptors in angiogenesis; complex partnerships.
  Cell Mol Life Sci, 63, 601-615.  
15948132 H.H.Keah, and M.T.Hearn (2005).
A molecular recognition paradigm: promiscuity associated with the ligand-receptor interactions of the activin members of the TGF-beta superfamily.
  J Mol Recognit, 18, 385-403.  
15929982 K.E.Gregory, R.N.Ono, N.L.Charbonneau, C.L.Kuo, D.R.Keene, H.P.Bächinger, and L.Y.Sakai (2005).
The prodomain of BMP-7 targets the BMP-7 complex to the extracellular matrix.
  J Biol Chem, 280, 27970-27980.  
14996829 E.del Re, J.L.Babitt, A.Pirani, A.L.Schneyer, and H.Y.Lin (2004).
In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2.
  J Biol Chem, 279, 22765-22772.  
15473835 S.J.Lee (2004).
Regulation of muscle mass by myostatin.
  Annu Rev Cell Dev Biol, 20, 61-86.  
15449706 W.Sebald, J.Nickel, J.L.Zhang, and T.D.Mueller (2004).
Molecular recognition in bone morphogenetic protein (BMP)/receptor interaction.
  Biol Chem, 385, 697-710.  
12919870 A.Chhabra, D.Tsou, R.T.Clark, V.Gaschen, E.B.Hunziker, and B.Mikic (2003).
GDF-5 deficiency in mice delays Achilles tendon healing.
  J Orthop Res, 21, 826-835.  
  15931280 K.C.Flanders, and J.K.Burmester (2003).
Medical applications of transforming growth factor-beta.
  Clin Med Res, 1, 13-20.  
14745974 R.Serra, and C.Chang (2003).
TGF-beta signaling in human skeletal and patterning disorders.
  Birth Defects Res C Embryo Today, 69, 333-351.  
12660162 T.B.Thompson, T.K.Woodruff, and T.S.Jardetzky (2003).
Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF-beta ligand:receptor interactions.
  EMBO J, 22, 1555-1566.
PDB codes: 1nys 1nyu
12077447 C.C.Boesen, S.A.Motyka, A.Patamawenu, and P.D.Sun (2002).
Crystallization and preliminary crystallographic studies of human TGF-beta type II receptor ligand-binding domain.
  Acta Crystallogr D Biol Crystallogr, 58, 1214-1216.  
  12121646 C.C.Boesen, S.Radaev, S.A.Motyka, A.Patamawenu, and P.D.Sun (2002).
The 1.1 A crystal structure of human TGF-beta type II receptor ligand binding domain.
  Structure, 10, 913-919.
PDB code: 1m9z
12357473 D.B.Everman, C.F.Bartels, Y.Yang, N.Yanamandra, F.R.Goodman, J.R.Mendoza-Londono, R.Savarirayan, S.M.White, J.M.Graham, R.P.Gale, E.Svarch, W.G.Newman, A.R.Kleckers, C.A.Francomano, V.Govindaiah, L.Singh, S.Morrison, J.T.Thomas, and M.L.Warman (2002).
The mutational spectrum of brachydactyly type C.
  Am J Med Genet, 112, 291-296.  
11850637 P.J.Hart, S.Deep, A.B.Taylor, Z.Shu, C.S.Hinck, and A.P.Hinck (2002).
Crystal structure of the human TbetaR2 ectodomain--TGF-beta3 complex.
  Nat Struct Biol, 9, 203-208.
PDB code: 1ktz
11453552 C.F.Gao, X.T.Kong, A.M.Gressner, and R.Weiskirchen (2001).
The expression and antigenicity identification of recombinant rat TGF-beta1 in bacteria.
  Cell Res, 11, 95.  
11774231 H.H.Keah, N.Allen, R.Clay, R.I.Boysen, T.Warner, and M.T.Hearn (2001).
Total chemical synthesis of human activin beta(A)[12-116] and related large-loop polypeptides.
  Biopolymers, 60, 279-289.  
11576166 H.Tiedemann, M.Asashima, H.Grunz, and W.Knöchel (2001).
Pluripotent cells (stem cells) and their determination and differentiation in early vertebrate embryogenesis.
  Dev Growth Differ, 43, 469-502.  
11170295 J.Rich, A.Borton, and X.Wang (2001).
Transforming growth factor-beta signaling in cancer.
  Microsc Res Tech, 52, 363-373.  
  11707292 J.Yue, and K.M.Mulder (2001).
Transforming growth factor-beta signal transduction in epithelial cells.
  Pharmacol Ther, 91, 1.  
11606186 T.K.Østbye, T.F.Galloway, C.Nielsen, I.Gabestad, T.Bardal, and Andersen Ø (2001).
The two myostatin genes of Atlantic salmon (Salmo salar) are expressed in a variety of tissues.
  Eur J Biochem, 268, 5249-5257.  
10799488 C.H.Ezal, C.D.Marion, and W.C.Smith (2000).
Primary structure requirements for Xenopus nodal-related 3 and a comparison with regions required by Xenopus nodal-related 2.
  J Biol Chem, 275, 14124-14131.  
11080174 M.Böttner, K.Krieglstein, and K.Unsicker (2000).
The transforming growth factor-betas: structure, signaling, and roles in nervous system development and functions.
  J Neurochem, 75, 2227-2240.  
10992290 M.T.Hearn, and P.T.Gomme (2000).
Molecular architecture and biorecognition processes of the cystine knot protein superfamily: part I. The glycoprotein hormones.
  J Mol Recognit, 13, 223-278.  
10844590 P.Ducy, and G.Karsenty (2000).
The family of bone morphogenetic proteins.
  Kidney Int, 57, 2207-2214.  
10652334 R.H.Baloh, M.G.Tansey, E.M.Johnson, and J.Milbrandt (2000).
Functional mapping of receptor specificity domains of glial cell line-derived neurotrophic factor (GDNF) family ligands and production of GFRalpha1 RET-specific agonists.
  J Biol Chem, 275, 3412-3420.  
10880444 T.Kirsch, J.Nickel, and W.Sebald (2000).
BMP-2 antagonists emerge from alterations in the low-affinity binding epitope for receptor BMPR-II.
  EMBO J, 19, 3314-3324.  
10092672 G.Wuytens, K.Verschueren, J.P.de Winter, N.Gajendran, L.Beek, K.Devos, F.Bosman, P.de Waele, M.Andries, A.J.van den Eijnden-van Raaij, J.C.Smith, and D.Huylebroeck (1999).
Identification of two amino acids in activin A that are important for biological activity and binding to the activin type II receptors.
  J Biol Chem, 274, 9821-9827.  
10075659 J.Pellaud, U.Schote, T.Arvinte, and J.Seelig (1999).
Conformation and self-association of human recombinant transforming growth factor-beta3 in aqueous solutions.
  J Biol Chem, 274, 7699-7704.  
9685266 A.Colavita, S.Krishna, H.Zheng, R.W.Padgett, and J.G.Culotti (1998).
Pioneer axon guidance by UNC-129, a C. elegans TGF-beta.
  Science, 281, 706-709.  
  9662508 B.R.Stockwell, and S.L.Schreiber (1998).
TGF-beta-signaling with small molecule FKBP12 antagonists that bind myristoylated FKBP12-TGF-beta type I receptor fusion proteins.
  Chem Biol, 5, 385-395.  
9786342 C.F.Ibáñez (1998).
Emerging themes in structural biology of neurotrophic factors.
  Trends Neurosci, 21, 438-444.  
9582381 D.J.Webb, J.Wen, L.R.Karns, M.G.Kurilla, and S.L.Gonias (1998).
Localization of the binding site for transforming growth factor-beta in human alpha2-macroglobulin to a 20-kDa peptide that also contains the bait region.
  J Biol Chem, 273, 13339-13346.  
9556597 G.Siemeister, D.Marmé, and G.Martiny-Baron (1998).
The alpha-helical domain near the amino terminus is essential for dimerization of vascular endothelial growth factor.
  J Biol Chem, 273, 11115-11120.  
9843440 J.Greenwald, V.Le, A.Corrigan, W.Fischer, E.Komives, W.Vale, and S.Choe (1998).
Characterization of the extracellular ligand-binding domain of the type II activin receptor.
  Biochemistry, 37, 16711-16718.  
9759503 J.Massagué (1998).
TGF-beta signal transduction.
  Annu Rev Biochem, 67, 753-791.  
  9684891 J.P.Tam, and Y.A.Lu (1998).
A biomimetic strategy in the synthesis and fragmentation of cyclic protein.
  Protein Sci, 7, 1583-1592.  
9521722 M.I.Ciglic, P.J.Jackson, S.A.Raillard, M.Haugg, T.M.Jermann, J.G.Opitz, N.Trabesinger-Rüf, S.A.Benner, and S.A.Benner (1998).
Origin of dimeric structure in the ribonuclease superfamily.
  Biochemistry, 37, 4008-4022.  
9726969 N.Beglova, L.LeSauteur, I.Ekiel, H.U.Saragovi, and K.Gehring (1998).
Solution structure and internal motion of a bioactive peptide derived from nerve growth factor.
  J Biol Chem, 273, 23652-23658.  
9478918 S.S.Huang, and J.S.Huang (1998).
A pentacosapeptide (CKS-25) homologous to retroviral envelope proteins possesses a transforming growth factor-beta activity.
  J Biol Chem, 273, 4815-4818.  
9748282 S.S.Huang, M.A.Cerullo, F.W.Huang, and J.S.Huang (1998).
Activated thyroglobulin possesses a transforming growth factor-beta activity.
  J Biol Chem, 273, 26036-26041.  
9356471 A.C.McPherron, and S.J.Lee (1997).
Double muscling in cattle due to mutations in the myostatin gene.
  Proc Natl Acad Sci U S A, 94, 12457-12461.  
9187648 C.Eigenbrot, and N.Gerber (1997).
X-ray structure of glial cell-derived neurotrophic factor at 1.9 A resolution and implications for receptor binding.
  Nat Struct Biol, 4, 435-438.
PDB code: 1agq
9150447 J.S.Munger, J.G.Harpel, P.E.Gleizes, R.Mazzieri, I.Nunes, and D.B.Rifkin (1997).
Latent transforming growth factor-beta: structural features and mechanisms of activation.
  Kidney Int, 51, 1376-1382.  
9218427 M.Lyon, G.Rushton, and J.T.Gallagher (1997).
The interaction of the transforming growth factor-betas with heparin/heparan sulfate is isoform-specific.
  J Biol Chem, 272, 18000-18006.  
  9071596 P.C.Marker, K.Seung, A.E.Bland, L.B.Russell, and D.M.Kingsley (1997).
Spectrum of Bmp5 mutations from germline mutagenesis experiments in mice.
  Genetics, 145, 435-443.  
  9170210 P.E.Gleizes, J.S.Munger, I.Nunes, J.G.Harpel, R.Mazzieri, I.Noguera, and D.B.Rifkin (1997).
TGF-beta latency: biological significance and mechanisms of activation.
  Stem Cells, 15, 190-197.  
9395284 R.Derynck, and X.H.Feng (1997).
TGF-beta receptor signaling.
  Biochim Biophys Acta, 1333, F105-F150.  
  9071585 S.J.Newfeld, R.W.Padgett, S.D.Findley, B.G.Richter, M.Sanicola, M.de Cuevas, and W.M.Gelbart (1997).
Molecular evolution at the decapentaplegic locus in Drosophila.
  Genetics, 145, 297-309.  
  11725095 D.H.Kim, and S.J.Kim (1996).
Transforming Growth Factor-beta Receptors: Role in Physiology and Disease.
  J Biomed Sci, 3, 143-158.  
8570652 D.L.Griffith, P.C.Keck, T.K.Sampath, D.C.Rueger, and W.D.Carlson (1996).
Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor beta superfamily.
  Proc Natl Acad Sci U S A, 93, 878-883.
PDB code: 1bmp
8917430 J.F.Goetschy, O.Letourneur, N.Cerletti, and M.A.Horisberger (1996).
The unglycosylated extracellular domain of type-II receptor for transforming growth factor-beta. A novel assay for characterizing ligand affinity and specificity.
  Eur J Biochem, 241, 355-362.  
  8617200 J.Saharinen, J.Taipale, and J.Keski-Oja (1996).
Association of the small latent transforming growth factor-beta with an eight cysteine repeat of its binding protein LTBP-1.
  EMBO J, 15, 245-253.  
8934607 J.Saltis, A.Agrotis, and A.Bobik (1996).
Regulation and interactions of transforming growth factor-beta with cardiovascular cells: implications for development and disease.
  Clin Exp Pharmacol Physiol, 23, 193-200.  
9027340 J.W.Lustbader, S.Pollak, L.Lobel, I.Trakht, S.Homans, J.M.Brown, and R.E.Canfield (1996).
Three-dimensional structures of gonadotropins.
  Mol Cell Endocrinol, 125, 21-31.  
  8852848 K.Wharton, R.P.Ray, S.D.Findley, H.E.Duncan, and W.M.Gelbart (1996).
Molecular lesions associated with alleles of decapentaplegic identify residues necessary for TGF-beta/BMP cell signaling in Drosophila melanogaster.
  Genetics, 142, 493-505.  
8988018 M.Haniu, J.Hui, Y.Young, J.Le, V.Katta, R.Lee, G.Shimamoto, and M.F.Rohde (1996).
Glial cell line-derived neurotrophic factor: selective reduction of the intermolecular disulfide linkage and characterization of its disulfide structure.
  Biochemistry, 35, 16799-16805.  
  8819159 P.R.Mittl, J.P.Priestle, D.A.Cox, G.McMaster, N.Cerletti, and M.G.Grütter (1996).
The crystal structure of TGF-beta 3 and comparison to TGF-beta 2: implications for receptor binding.
  Protein Sci, 5, 1261-1271.
PDB codes: 1tgj 1tgk
8620887 R.Ruppert, E.Hoffmann, and W.Sebald (1996).
Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity.
  Eur J Biochem, 237, 295-302.  
  9552326 S.S.Duggirala, R.C.Mehta, and P.P.DeLuca (1996).
Interaction of recombinant human bone morphogenetic protein-2 with poly(d,l lactide-co-glycolide) microspheres.
  Pharm Dev Technol, 1, 11-19.  
  8835843 T.L.Tuan, D.T.Cheung, L.T.Wu, A.Yee, S.Gabriel, B.Han, L.Morton, M.E.Nimni, and F.L.Hall (1996).
Engineering, expression and renaturation of targeted TGF-beta fusion proteins.
  Connect Tissue Res, 34, 1-9.  
7777520 G.Venkataraman, V.Sasisekharan, C.L.Cooney, R.Langer, and R.Sasisekharan (1995).
Complex flexibility of the transforming growth factor beta superfamily.
  Proc Natl Acad Sci U S A, 92, 5406-5410.  
7852346 H.Y.Lin, A.Moustakas, P.Knaus, R.G.Wells, Y.I.Henis, and H.F.Lodish (1995).
The soluble exoplasmic domain of the type II transforming growth factor (TGF)-beta receptor. A heterogeneously glycosylated protein with high affinity and selectivity for TGF-beta ligands.
  J Biol Chem, 270, 2747-2754.  
7492567 J.M.Yingling, X.F.Wang, and C.H.Bassing (1995).
Signaling by the transforming growth factor-beta receptors.
  Biochim Biophys Acta, 1242, 115-136.  
  7744882 J.V.Heymach, and E.M.Shooter (1995).
The biosynthesis of neurotrophin heterodimers by transfected mammalian cells.
  J Biol Chem, 270, 12297-12304.  
8536276 M.Hoefer, and F.A.Anderer (1995).
Anti-(transforming growth factor beta) antibodies with predefined specificity inhibit metastasis of highly tumorigenic human xenotransplants in nu/nu mice.
  Cancer Immunol Immunother, 41, 302-308.  
7583638 N.W.Isaacs (1995).
Cystine knots.
  Curr Opin Struct Biol, 5, 391-395.  
  7585661 P.Nørgaard, S.Hougaard, H.S.Poulsen, and M.Spang-Thomsen (1995).
Transforming growth factor beta and cancer.
  Cancer Treat Rev, 21, 367-403.  
  7796806 R.Urfer, P.Tsoulfas, L.O'Connell, D.L.Shelton, L.F.Parada, and L.G.Presta (1995).
An immunoglobulin-like domain determines the specificity of neurotrophin receptors.
  EMBO J, 14, 2795-2805.  
7890765 S.B.Woo, D.E.Timm, and K.E.Neet (1995).
Alteration of NH2-terminal residues of nerve growth factor affects activity and Trk binding without affecting stability or conformation.
  J Biol Chem, 270, 6278-6285.  
7768960 S.Sankar, N.Mahooti-Brooks, M.Centrella, T.L.McCarthy, and J.A.Madri (1995).
Expression of transforming growth factor type III receptor in vascular endothelial cells increases their responsiveness to transforming growth factor beta 2.
  J Biol Chem, 270, 13567-13572.  
  7922031 H.Wu, J.W.Lustbader, Y.Liu, R.E.Canfield, and W.A.Hendrickson (1994).
Structure of human chorionic gonadotropin at 2.6 A resolution from MAD analysis of the selenomethionyl protein.
  Structure, 2, 545-558.
PDB code: 1hcn
14731645 J.Massagué, L.Attisano, and J.L.Wrana (1994).
The TGF-beta family and its composite receptors.
  Trends Cell Biol, 4, 172-178.  
8294500 J.Taipale, K.Miyazono, C.H.Heldin, and J.Keski-Oja (1994).
Latent transforming growth factor-beta 1 associates to fibroblast extracellular matrix via latent TGF-beta binding protein.
  J Cell Biol, 124, 171-181.  
  7950318 N.A.Wall, and B.L.Hogan (1994).
TGF-beta related genes in development.
  Curr Opin Genet Dev, 4, 517-522.  
  7703837 R.A.Bradshaw, J.Murray-Rust, C.F.Ibáñez, N.Q.McDonald, R.Lapatto, and T.L.Blundell (1994).
Nerve growth factor: structure/function relationships.
  Protein Sci, 3, 1901-1913.  
8174548 S.Jungbluth, K.Bailey, and Y.A.Barde (1994).
Purification and characterisation of a brain-derived neurotrophic factor/neurotrophin-3 (BDNF/NT-3) heterodimer.
  Eur J Biochem, 221, 677-685.  
  8508763 C.F.Ibáñez, L.L.Ilag, J.Murray-Rust, and H.Persson (1993).
An extended surface of binding to Trk tyrosine kinase receptors in NGF and BDNF allows the engineering of a multifunctional pan-neurotrophin.
  EMBO J, 12, 2281-2293.  
14731534 H.Y.Lin, and H.F.Lodish (1993).
Receptors for the TGF-beta superfamily: multiple polypeptides and serine/threonine kinases.
  Trends Cell Biol, 3, 14-19.  
8241386 J.A.Kornblatt, M.J.Kornblatt, G.H.Hoa, and A.G.Mauk (1993).
Responses of two protein-protein complexes to solvent stress: does water play a role at the interface?
  Biophys J, 65, 1059-1065.  
7690965 J.K.Burmester, S.W.Qian, A.B.Roberts, A.Huang, S.Amatayakul-Chantler, L.Suardet, N.Odartchenko, J.A.Madri, and M.B.Sporn (1993).
Characterization of distinct functional domains of transforming growth factor beta.
  Proc Natl Acad Sci U S A, 90, 8628-8632.  
  8069627 J.Murray-Rust, N.Q.McDonald, T.L.Blundell, M.Hosang, C.Oefner, F.Winkler, and R.A.Bradshaw (1993).
Topological similarities in TGF-beta 2, PDGF-BB and NGF define a superfamily of polypeptide growth factors.
  Structure, 1, 153-159.  
7916656 K.Basler, T.Edlund, T.M.Jessell, and T.Yamada (1993).
Control of cell pattern in the neural tube: regulation of cell differentiation by dorsalin-1, a novel TGF beta family member.
  Cell, 73, 687-702.  
8490958 N.Q.McDonald, and W.A.Hendrickson (1993).
A structural superfamily of growth factors containing a cystine knot motif.
  Cell, 73, 421-424.  
  7503942 N.Tahara, H.Yasumitsu, and M.Umeda (1993).
Synthetic peptide-generated monoclonal antibodies to transforming growth factor-beta 1.
  Hybridoma, 12, 441-453.  
8488558 R.A.Bradshaw, T.L.Blundell, R.Lapatto, N.Q.McDonald, and J.Murray-Rust (1993).
Nerve growth factor revisited.
  Trends Biochem Sci, 18, 48-52.  
8298646 T.Meitinger, A.Meindl, P.Bork, B.Rost, C.Sander, M.Haasemann, and J.Murken (1993).
Molecular modelling of the Norrie disease protein predicts a cystine knot growth factor tertiary structure.
  Nat Genet, 5, 376-380.  
  8395914 W.W.He, M.L.Gustafson, S.Hirobe, and P.K.Donahoe (1993).
Developmental expression of four novel serine/threonine kinase receptors homologous to the activin/transforming growth factor-beta type II receptor family.
  Dev Dyn, 196, 133-142.  
1419064 A.H.Reddi (1992).
Regulation of cartilage and bone differentiation by bone morphogenetic proteins.
  Curr Opin Cell Biol, 4, 850-855.  
1333888 J.L.Wrana, L.Attisano, J.Cárcamo, A.Zentella, J.Doody, M.Laiho, X.F.Wang, and J.Massagué (1992).
TGF beta signals through a heteromeric protein kinase receptor complex.
  Cell, 71, 1003-1014.  
1332976 M.B.Sporn, and A.B.Roberts (1992).
Transforming growth factor-beta: recent progress and new challenges.
  J Cell Biol, 119, 1017-1021.  
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB code is shown on the right.